INTRODUCTION
Hydrolases containing the Gx 5 Ex 7 REUxEExGU 1 "Nudix-type" motif comprise a protein superfamily whose members have been proposed to act as "surveillance enzymes" (2) , that function both to eliminate potentially toxic metabolites from the cell, as well as to regulate concentrations and availability of substrates, cofactors and signaling molecules (3) . Almost all of the substrates for these hydrolases are nucleotide diphosphates. The unique exception is provided by a subgroup of phosphohydrolases (DIPPs) 2 that preferentially attack diphosphoinositol polyphosphates (4;5).
The diphosphoinositol polyphosphates provide the most extreme example of the degree to which phosphate groups can be clustered in high density around the inositol ring.
gene in yeast, which encodes DINS activity (11) , was shown to impede vacuolar morphogeneis in a manner that likely represents a vesicle trafficking defect (12;13) .
Several additional functions have been ascribed to diphosphoinositol polyphosphates.
For example, in yeast, the turnover of diphosphoinositol polyphosphates plays roles in homologous recombination (14) , the maintenance of cell-wall integrity (13) , and in mediating cellular responses to environmental stress (13) . The g5R gene in the African swine fever virus was recently found to encode an active diphosphoinositol polyphosphate phosphohydrolase, suggesting a role for these compounds in viral morphogenesis (15) . Finally, genetic manipulation of the turnover of diphosphoinositol polyphosphates in ovarian carcinoma cells affects apoptotic processes (16) . To rationalize how such diverse biological processes can all be regulated by diphosphoinositol polyphosphates, it has been proposed that these compounds are ligands that modify the functions of certain proteins (11;17) . In such an event, polyphosphate turnover can be envisaged to comprise a molecular switch (11;17;18) , akin to G-proteins that function as a binary switch between two interconvertible GTPbound active and GDP-bound inactive states.
The rate of turnover of diphosphoinositol polyphosphates may be regulated in a combinatorial manner by cell-and developmental-specific expression of the various isoforms of DIPP and DINS. For example, three distinct DINS enzymes are known to phosphorylate InsP 6 to PP-InsP 5 , and these proteins differ in both catalytic activity and subcellular localization (11;14) . As for the phosphohydrolases, we have previously described three human isoforms of DIPP, which we named type 1, type2 and type 2 (4;5). These three DIPP isoforms each have differing catalytic efficiencies, and their expression is apparently regulated by a variety of molecular processes (4) . For by guest on http://www.jbc.org/ Downloaded from example, the two type 2 proteins are transcribed from a single gene by a specialized form of alternate mRNA splicing known as intron boundary skidding (19) . Moreover, both hDIPP2 and hDIPP2 are translated from an array of mRNA transcripts of differing lengths which may have distinct turnover rates (4) . We now add to the range of enzymes regulating diphosphoinositol polyphosphate turnover with the molecular and biochemical characterization of a new pair of hDIPP isoforms: type 3 and type 3 .
EXPERIMENTAL PROCEDURES

DNA probe synthesis and hybridization
All DNA probes used in this study were generated with a PCR DIG Probe Synthesis Kit of the hDIPP3 clone is reported, therefore, as the first non-C nucleotide sequenced.
Site-directed mutagenesis of hDIPP3
A single nucleotide mutation of hDIPP3 was performed with the QuickChange SiteDirected Mutagenesis Kit (Stratagene) with mutation oligos: 5'-
( s e n s e ) a n d 5 ' -CGTTCTGTGCTTGCGGTCCTGGTTCTGTTCG-3' (antisense). This results in a cDNA which codes for hDIPP3 , in which Arg89 replaces Pro89 in hDIPP3 . The coding region to either 250ng of total RNA for a positive control transcript (SHGC-32313) that escapes inactivation (21), or 250 ng for hDIPP3 or 50 ng for hDIPP3 . The hDIPP3 transcript was amplified using as primers 5'-CAAAGCCAGGCACAGTGTTA-3' (sense) and 5'-GGGGCATGGTCAAATTTAGG-3' (antisense) for 40 cycles at an annealing temperature of 58°C. The hDIPP3 transcript was amplified using as primers 5'-TTGCCTCTCTCACTGATCCA-3' (sense) and 5'-GCAGCCTCTTTCCTAAATGC-3'
(antisense) for 30 cycles with a 55°C annealing temperature.
Northern and dot blotting
Northern, dot and arrayed library blots were pre-hybridized in DIG Easy Hyb solution Human Multiple Tissue Expression Array dot blots (Clontech) were hybridized with a probe (P4) which was generated with the following primers: 5'-GCGAGGACGAGGTCCTGT-3' (sense) and 5'-GCTCATCTGTGCTTCACA (antisense). Probe P4 is specific for the hDIPP3 coding region, plus approximately 100 bp of the 3'-UTR. The blot was hybridized as described above, washed twice for 15 min each to a stringency of 0.5 X SSC/ 0.1% SDS at 50 0 C, and processed for chemiluminescent detection of signal as described above.
Northern analysis was also performed in an identical manner with a Human Multiple Tissue
Northern blot (Clontech, Palo Alto, CA), using a hDIPP3 coding region probe (P2), by guest on September 1, 2017
http://www.jbc.org/ Downloaded from generated using the following primers: 5'-GCGAGGACGAGGTCCTGT-3' (sense) and 5'-GGGGCCATGGAGTTTCCA-3' (antisense). This blot was washed twice for 15 min each to a stringency of 0.1 X SSC/ 0.1% SDS at 50 0 C, then chemiluminescent detection was performed as described above. The blot was subsequently stripped with boiling 1% SDS and re-probed with a human -actin probe (P3) under the same hybridization and wash conditions. P3 was generated from a cDNA of human -actin (Clontech) using the following primers 5-ATCGCCGCGCTCGTCGTCG-3' (sense) and 5'-CACCGGAGTCCATCACG-3' (antisense).
Expression and purification of recombinant hDIPP proteins
Recombinant hDIPP1 and hDIPP2 proteins were prepared as previously described (4;5).
The entire coding regions of hDIPP3 and hDIPP3 , prepared as described above, were amplified by PCR using 5'-GATCGTCGACATGAAGTGCAAACCCAACCAG-3' (sense) and 5'-GATCGAGCTCCGGGATCGCTATCTGGCGAGG-3' (antisense) primers containing Sal I and Sac I restriction sites respectively. The resultant PCR product was digested with these enzymes, agarose-gel purified, and ligated into the cognate sites of vector pIVEX-2.3MCS (Roche, Manheim, Germany) and the construct was completely sequenced to verify its structure. The recombinant, poly(His)-tagged hDIPP3 and hDIPP3 proteins were synthesized in 1 ml volume of the Rapid Translation System RTS 500 (Roche), according to the manufacturer's protocol. The extract was subsequently bound, at 4 o C for imidazole, by gravity flow. Most of the protein eluted in the second 1 ml fraction, which was dialyzed twice against 500 ml of Buffer A, and then the final enzyme preparations were stored at -70 o C.
Antibodies
The peptide NGNSMAPSSPDSDP, representing the C-terminal 14 amino acid residues of hDIPP3, was synthesized with an N-terminal C residue, and conjugated to Keyhole Limpet
Hemocyanin protein (SigmaGenosys, The Woodlands, TX). This conjugated peptide was used to raise antisera in New Zealand White rabbits (SigmaGenosys) following standard protocols. The anti-hDIPP2 anti-peptide antibodies were prepared as previously described (4) . The anti-hDIPP1 polyclonal antibodies against recombinant poly (His)-hDIPP1 hDIPP1 (5) were raised in the rabbit. All serum samples were stored in aliquots at -80 o C.
Western analysis
Recombinant hDIPP1 and hDIPP2 were prepared as previously described (4;5). Human in 50 mM Hepes-NaOH (pH 7.6), 1 mM MnCl 2 , 2 mM DTT and 100 µg BSA/ml in a final volume of 100 µl for 30 min at 37°C. The reaction was stopped and the products separated from residual substrate by boronate chromatography as previously described (26) , and the products were detected by liquid scintillation counting. On the 3 rd day, cells (in a 6 well plate) were transfected with 5 µg plasmid DNA encoding either GFP, GFP-hDIPP3 , or GFP-hDIPP3 , using Lipofectamine 2000 (Invitrogen), according to the manufacturer's recommended protocol. The cDNA for the GFP-DIPP fusion constructs were prepared by subcloning the coding region of hDIPP3 and into the phGFP105C1 vector (27) . Approximately 80% of the cells were estimated to express GFP.
Cells were quenched with 1 ml 0.6 M perchloric acid supplemented with 0.1 mg/ml InsP 6 .
Lysates were neutralized (28) B. One ml fractions were collected and the radiolabeled inositol phosphates were determined by liquid scintillation counting.
Aliquots of non-radiolabeled HEK293 cells were also transfected with plasmid DNA encoding either GFP or the GFP-hDIPP3 fusion constructs as described above. Cells were lysed with 50 mM Tris-HCl (pH7.4), 150 mM NaCl, 1 mM EDTA and 1 % Triton X-100, followed by centrifugation at 12,000g for 20 min. Aliquots of the supernatant were analyzed by SDS-PAGE on 10% Bis-Tris NuPage gels with MES buffer; GFP-fusion proteins were detected by anti-GFP antibody (Invitrogen), or by anti-hDIPP3 antisera.
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The sequence alignments described in this study were obtained with Peptool v2 and Genetool v1 (Biotools Inc., Alberta, Canada).
RESULTS AND DISCUSSION
Identification of cDNAs encoding two hDIPP3 isoforms.
We have previously cloned hDIPP1 and hDIPP2 cDNAs (4;5). In the current study we first searched for novel hDIPP isoforms by screening an arrayed human cDNA library with a 492 bp probe spanning the coding region of hDIPP2 (P1, see under Experimental Procedures). A novel 2020 bp cDNA was identified that encodes a 165 amino-acid residue protein (Fig. 1A) . In the alignments shown in Fig. 1A , the sequence of this new protein is 90% identical to residues 2-165 in hDIPP2, and 74% identical to residues 2-164 in hDIPP1.
We therefore propose that our new protein represents a novel DIPP isoform, which we have named type 3 ( Fig. 1 ). This hDIPP3 protein has particularly strong conservation of a 33 residue active site found in hDIPP1 and hDIPP2 (Fig. 1A) , that is, the Nudix core domain (see ref (3)), flanked by an N-terminal GGG tripeptide and a C-terminal Gx 2 Gx 6 G sequence (see Fig. 1A and ref (29)).
The hDIPP3 cDNA initiation codon occurs within a weak Kozak consensus (AGGATGA) After we identified the hDIPP3 cDNA, the GenBank database acquired the nt sequences of two human cDNAs (accession numbers BC009942 (2376 kb) and AK001490 (2282 kb))
that are identical to each other except that the latter is shorter at the 5'-end, and lacks a poly[A] tail. These two cDNAs share important similarities with our own hDIPP3 cDNA, particularly across the coding regions (Fig. 2) . It is particularly notable that the protein predicted to be encoded by clones BC009942 and AK001490, which we have named hDIPP3 ( Fig. 1) is only one amino acid residue different from hDIPP3 . The Pro89 residue in hDIPP3 is replaced by an Arg residue in hDIPP3 (Fig. 1B) . This Arg is also conserved in hDIPP1 and hDIPP2 (Fig. 1A) , and is part of a positively-charged amino-acid cluster that serves a catalytic role (29) . kcal/mol) which could facilitate the formation of secondary structures that comprise recognition elements for regulatory proteins. The 3'-NTS also has 5 ATTTA pentamers and
Pattern of expression of hDIPP3
The pattern of expression of DIPP3 mRNA was studied using a human Multiple Tissue
Expression Array (Fig. 3) . A probe (P4, see under Experimental Procedures), that is specific for the coding region of hDIPP3, revealed a prominent signal from testis mRNA (panel F8, Fig. 3A) , plus some weaker signals in mRNA isolated from various regions of the brain (Fig. 3A) . All of the other tissues that were tested did not show a substantial signal (Fig. 3A) . In comparison, hDIPP2 expression is much more widespread (Fig. 3B) ,
and is particularly strong in heart, consistent with previous determinations (4). The restricted expression of hDIPP3 was verified when a similar dot blot analysis was performed on a human RNA Master Blot (Clontech), probed with a 416 bp probe specific for the hDIPP3 3'-NTS (data not shown). Additional Northern analysis (Fig. 4) identified two candidate hDIPP3 mRNAs in the testis (2.2 -2.6 kb), that correspond closely in size to the hDIPP3 and hDIPP3 cDNAs that we have identified (2 -2.4 kb, Fig. 2 ). No significant
Northern signal was observed in spleen, thymus, uterus, small intestine and peripheral blood leucocytes (Fig. 4) in agreement with the dot blot analysis (Fig. 3) .
In order to study whether the hDIPP3 protein was expressed in vivo, we generated antipeptide antibodies against the unique C-terminus of hDIPP3 (see Fig. 1 and Experimental Procedures). These anti-hDIPP3 antibodies detected recombinant, His-tagged hDIPP3
(which migrates on SDS-PAGE at approximately 25 kDa), and there was no significant cross-reactivity with either hDIPP2 or hDIPP1 (Fig. 5) . Likewise, the hDIPP2 antibodies we derived previously (4) do not cross-react significantly with either hDIPP1 or hDIPP3 (Fig. 5) . The Northern data described above (Figs 3, 4) indicate hDIPP3 is most highly expressed in testis. Therefore, we performed Western analysis of extracts prepared from two human testis cell lines, and we obtained a signal corresponding to a protein of 22.7 kDa, close to that expected for hDIPP3 (Fig. 5, 6 ). No corresponding signals were observed when preimmune serum was used (Fig. 6 ), or when extracts of either HEK293 or Jurkat cells were analyzed (Fig. 6) , consistent with the restricted expression of hDIPP3 (Figs 3,4) . It should be noted, nevertheless, that the anti-hDIPP3 antibodies also recognized several high molecular weight proteins (Fig. 6 ).
The genes that encode hDIPP3 are located on Chromosome X
Sequence alignments assigned both hDIPP3 cDNAs to a human chromosome X contig which in the GenBank database has been assigned to the region Xp11.1 -11.22 (Fig. 7) .
A more precise assignment of this contig to Xp11.22 is given on the Sanger website as of June 2002 (http://www.sanger.ac.uk). The two genes are only 152 kbp apart; the gene is encoded on the complementary DNA strand relative to the gene. It is also important to note that this genomic sequence confirms the presence of two separate genes encoding both hDIPP3 (residue 89 = Pro) and hDIPP3 (residue 89 = Arg). The human genome committee has approved that these genes be named NUDT10 and NUDT11 respectively.
Both genes have predicted introns (A1, A2 and B1; Fig. 7 ) which contain the necessary AG dinucleotide immediately upstream of the 3' exon ligation site. Both genes are also expressed (see below), so it is unlikely that either NUDT10 or NUDT11 are pseudogenes.
The predicted intron/exon structures of the two genes are similar (Fig. 7) . There is also substantial similarity in the sequences of aligned introns B1 and A2 (Fig. 7) . Furthermore, upstream of the exon encoding the hDIPP3 5'-NTS, there is genomic sequence that shows considerable similarity to the region of the gene that includes intron A1 and its own upstream genomic sequence (Fig. 7) . These comparisons, when taken together with the exonic sequence similarities, suggest that the two hDIPP3 genes arose by a gene duplication event. The maintenance of a pair of duplicated, expressed genes in the human genome almost always reflects the fact that the functions of the resultant gene products are not fully redundant (34) . Since the catalytic activities of the two hDIPP3 isoforms are very similar (see below), further studies are necessary in order to determine the significance of there being two DIPP3 genes.
As the NUDT10 and NUDT11 genes are X-linked, the possibility was raised that human females might have double the gene dosage of males (for example, in the brain, Fig. 3 ), unless, as is the case for most X-linked genes, there is transcriptional inactivation of one of female's two X-chromosomes (20) . On the other hand, some genes are able to escape this inactivation process (21) . We therefore determined whether the DIPP3 proteins are subject to or escape X chromosome inactivation in mouse/human somatic cell hybrids that retain human inactive (Xi) chromosomes. Prior to these experiments, we determined if both DIPP3 and DIPP3 genes were expressed in the original female human fibroblasts that provided the source material for the hybrids. Primers for the RT-PCR analysis (see Experimental Procedures) were designed to distinguish between the different 3'-NTS of the and hDIPP3 mRNAs. Although Northern analysis primarily detected gene expression in testis (Figs. 3,4) , the amplification of both hDIPP3 and hDIPP3 transcripts from cDNA derived from fibroblasts confirms at least low expression of both genes (Fig. 8, lane 1) . The two genes were also expressed in the mouse/human hybrids containing the active X chromosome (Fig. 8) . Restriction digestion of amplification products using enzymes that specifically recognize a site only within hDIPP3 (Hinf I) or only within hDIPP3 (Nhe I)
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http://www.jbc.org/ Downloaded from confirmed primer specificity (data not shown). Neither of the two hDIPP3 genes was expressed in hybrids containing inactive X chromosomes, thereby establishing that both genes are subject to X inactivation in human females (Fig. 8) . Amplification of the EST SHGC-32313, a transcript that escapes inactivation (21) served as a positive control (Fig.   8 ). These data (Fig. 8) show that the two hDIPP3 genes can be co-expressed in the same cell type.
Compared to the hDIPP3 gene, detection of expression of the hDIPP3 gene required 5-fold higher levels of RNA, a larger number of PCR cycles, and a slightly higher annealing temperature (see under Experimental Procedures). This is consistent with a lower level of expression of hDIPP3 in this cell type. Nevertheless, the physiological impact of differential expression of the two genes is unclear, as they have similar catalytic properties (see below).
Catalytic Activities of hDIPP3 and hDIPP3 .
The hDIPP3 and isoforms were individually expressed in an in vitro translation system as poly(His)-tagged proteins (see Experimental Procedures), and then the proteins were purified (Fig.9A) . Following SDS-PAGE, the sizes of both recombinant DIPP3 proteins was estimated to be 25 kDa (Fig.9A) , a little higher than the theoretical size of 20.3 kDa, but consistent with the apparent size of native hDIPP3 in extracts prepared from human testis cell lines (Fig. 6 ). Both enzymes specifically hydrolyzed the -phosphate from PP-InsP 5 , yielding InsP 6 (Fig. 9B) . The k cat value for hydrolysis of PP-InsP 5 by hDIPP3 was 40%
higher than the corresponding value for hDIPP3 ; the substrate affinities of the two enzymes were similar (50-90 nM, than the values we previously reported for hDIPP1 (22) and hDIPP2 (4), but only 1.4 -3 fold lower than those for hDIPP2 (4) . Indeed, among hDIPP1, hDIPP2 and hDIPP2 , it is the latter's catalytic domain that is the most similar to that of hDIPP3 (Fig. 1A) , including conservation of a Gln residue (Gln86 in hDIPP3, Fig. 1B ) that is responsible for DIPP2 being several-fold less active than hDIPP2 (4). was 2.7-fold higher than the corresponding value for hDIPP3 . Overall, the single amino acid difference between hDIPP3 and hDIPP3 has only a minor impact upon hydrolysis of diphosphoinositol polyphosphates (Table 1) .
While diphosphoinositol polyphosphates are the optimum substrates for the human DIPP1 and 2 isoforms, these enzymes also display lesser activity towards a very different polyphosphate, namely, Ap 6 A (4;22). Ap 6 A may have extracellular signaling roles (35) but in addition it appears to be a downstream effector of a signaling cascade that regulates cardiac K ATP channels (36) and ryanodine receptors (37) . Thus, studies into the hydrolysis and inactivation of Ap 6 A is of interest. We have found that the hDIPP3 enzymes attack Ap 6 A ( Table 1) . As with the other hDIPPs, the specificity constant for Ap 6 A hydrolysis is considerably (100-200 fold) lower than the corresponding value for PP-InsP 5 (Table 1) .
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Intracellular levels of Ap 6 A are in the low micromolar range (35) , which is similar to the levels of the diphosphoinositol polyphosphates (6), so the latter are likely to be the preferred substrates in vivo, provided that we assume uniform distribution of enzymes and substrates throughout the cell. We also found that neither hDIPP3 isoform metabolized dGTP (data not shown), which is a substrate for several other Nudix-type enzymes (3).
The identification of the hDIPP3 isoforms therefore extends the exception to the Nudix generality (3;38) that all members of this enzyme family prefer nucleoside diphosphate derivatives as substrates.
We also investigated whether the hDIPP3 and hDIPP3 enzymes would hydrolyze PP- rate was estimated to be approximately 80% (data not shown). We did not detect any hDIPP in wild-type HEK cells using antibodies against either hDIPP3 (Fig. 10) or hDIPP1 or hDIPP2 (data not shown). However, in transfected cells, the GFP-hDIPP3 fusion protein was detected by Western analysis using either anti-hDIPP3 or anti-GFP antibodies (Fig.   10 ). Both fusion proteins were expressed to a similar extent (Fig. 10). [ 3 H]inositol-labeled cells were also transfected in parallel, and cell extracts were analyzed by HPLC to determine the levels of PP-[
Concluding Comment: hDIPP diversity
Following on from our initial description of hDIPP1 (5), and later hDIPP2 and hDIPP2 (4),
we have now characterized two new members of this family, which we have named hDIPP3 and hDIPP3 . Thus, our experiments described in this report bring to five the number of known human DIPP proteins. BLAST searches of the GenBank databases have not identified any further isoforms. Together with the three isoforms of DINS that have been characterized to date (11;14) , the cell has at its disposal a number of enzymes which may be expressed in a combinatorial manner so as to fine-tune the metabolic cycling and hence the physiological function of diphosphoinositol polyphosphates. Our data indicate that each of the hDIPPs has distinct catalytic parameters, and that the corresponding mRNAs offer differing possibilities for the regulation of gene expression. This is borne out by our new data showing that hDIPP3 is preferentially expressed in testis and the brain. The kinetic parameters for the hDIPP3 isoforms were determined as described under 
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